Yan Zhou

Radiopharmaceuticals driving the transition from metabolic to targeted precision molecular imaging in neurodegenerative diseases

Neurodegenerative diseases (NDDs) are characterized by overlapping clinical phenotypes and heterogeneous proteinopathies, which pose substantial challenges for early and accurate diagnosis. Molecular imaging with radiopharmaceuticals has revolutionized the field by enabling the in vivo visualization of disease-specific...